Europe's medicines watchdog partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease ...

The article provides an overview of recent developments in the healthcare sector, including Novo Nordisk's phase-out of ...

If the European Commission decides to grant sales of the medicine, it will be the first Alzheimer's medicine available in the ...